🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Trump Touts Vaccine Rollout for U.S. in April, Sees 'Very Rapid' Approvals

Published 2020-11-13, 04:04 p/m
© Reuters.

By Yasin Ebrahim

Investing.com - President Donald Trump on Friday said he expected Pfiizer's vaccine to be approved "very soon," and talked up the prospect of a widespread roll out of the inoculation to the population as soon as April. 

The president credited the positive progress to Operation Warp Speed, a project aimed at speeding up the production of Covid-19 vaccines. There are three other vaccines that will arrive within a few weeks, and the delivery would be "very rapid," the president said.

The vaccine would be distributed to front line workers and vulnerable Americans immediately once available. Trump said, however, New York would be made to wait for a vaccine after NY Gov. Andrew Cuomo did not grant permission for the rollout of a vaccine, preferring to wait amid concerns about the safety of a vaccine.      

In his first address since falsely claiming to have won the election, Trump has seen his path to the White House - via legal challenges on allegations of voter fraud in several states - narrow after media networks projected Biden to win Georgia and Trump to take North Carolina, taking their electoral college vote totals to 306 and 232, respectively.      

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.